3/26
11:02 am
rckt
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? [Yahoo! Finance]
Medium
Report
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? [Yahoo! Finance]
3/12
07:38 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
3/3
10:06 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $29.00 to $15.00. They now have a "neutral" rating on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $29.00 to $15.00. They now have a "neutral" rating on the stock.
3/3
10:06 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target raised by analysts at Scotiabank from $51.00 to $52.00. They now have a "sector outperform" rating on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target raised by analysts at Scotiabank from $51.00 to $52.00. They now have a "sector outperform" rating on the stock.
3/3
08:10 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $39.00 to $36.00. They now have a "buy" rating on the stock.
Medium
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $39.00 to $36.00. They now have a "buy" rating on the stock.
3/2
07:27 am
rckt
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? [Yahoo! Finance]
Medium
Report
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? [Yahoo! Finance]
2/28
10:40 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Chardan Capital from $62.00 to $54.00. They now have a "buy" rating on the stock.
Low
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Chardan Capital from $62.00 to $54.00. They now have a "buy" rating on the stock.
2/28
08:13 am
rckt
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Needham & Company LLC from $52.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Needham & Company LLC from $52.00 to $42.00. They now have a "buy" rating on the stock.
2/27
04:32 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress [Yahoo! Finance]
Low
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress [Yahoo! Finance]
2/27
04:01 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
Low
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
1/2
04:00 pm
rckt
Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference